Abstract:Hyperglycemia caused by diabetes mellitus could increase the risk of diabetic cardiomyopathy. However, to the best of our knowledge, the underlying mechanism of this process is still not fully explored. Thus, developing ways to prevent hyperglycemia can be beneficial for diabetic patients. The present study was designed to investigate the influence of metoprolol and bisoprolol on the cardiomyocytic hypertrophy of neonatal rat cardiomyocytes. Cardiomyocytes were cultured in two types of media: One with low glucose levels and one with high glucose levels. Cardiomyocytes cultured in high glucose were further treated with the following: A protein kinase C (PKC) inhibitor, an NF-kappa B inhibitor, metoprolol or bisoprolol. The pulsatile frequency, cellular diameter and surface area of cardiomyocytes were measured. Protein content and [H-3]-leucine incorporation were determined, atrial natriuretic peptide (ANP), alpha-myosin heavy chain (alpha-MHC) and beta-myosin heavy chain (beta-MHC) mRNA levels were calculated by reverse transcription-quantitative PCR, while the expression and activation of PKC-alpha, PKC-beta(2), NF-kappa B, tumor necrosis factor-alpha (TNF-alpha), and c-fos were detected by western blotting. Metoprolol or bisoprolol were also used in combination with PKC inhibitor or NF-kappa B inhibitor to determine whether the hypertrophic response would be attenuated to a lower extent compared with metroprolol or bisoprolol alone. Cardiomyocytes cultured in high glucose presented increased pulsatile frequency, cellular diameter, surface area, and protein content and synthesis, higher expression of ANP and beta-MHC, and lower alpha-MHC expression. High glucose levels also upregulated the expression and activation of PKC-alpha, PKC-beta(2), NF-kappa B, TNF-alpha and c-fos. Metoprolol and bisoprolol partly reversed the above changes, while combined use of metoprolol or bisoprolol with PKC inhibitor or NF-kappa B inhibitor further ameliorated the hypertrophic response mentioned above to lower levels compared with using metroprolol or bisoprolol alone. In conclusion, metoprolol and bisoprolol could prevent hypertrophy of cardiomyocytes cultured in high glucose by the inhibition of the total and phospho-PKC-alpha, which could further influence the PKC-alpha/NF-kappa B/c-fos signaling pathway.

PPARγ–PI3K/AKT–NO Signal Pathway is Involved in Cardiomyocyte Hypertrophy Induced by High Glucose and Insulin

O-GlcNAcylation Involvement in High Glucose-Induced Cardiac Hypertrophy Via ERK1/2 and Cyclin D2

Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF-κB/c-fos signaling pathway.

Metoprolol and Bisoprolol Ameliorate Hypertrophy of Neonatal Rat Cardiomyocytes Induced by High Glucose Via the PKC/NF-B/c-fos Signaling Pathway (vol 19, Pg 871, 2020)

The signal transduction pathway of PKC/NF-κB/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats

The signal transduction pathway of PKC/NF-kappa B/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats.

Reverse Effect of Protein Kinase C Inhibitor Ro-31-8220 on the Hypertrophy of Cardiomyocytes of Neonatal Rats Induced by High Glucose Levels

Activation Of Pi3k Gamma/Akt Pathway Increases Cardiomyocyte Hmgb1 Expression In Diabetic Environment

Curcumin Attenuates Cardiomyocyte Hypertrophy Induced by High Glucose and Insulin Via the PPARγ/Akt/NO Signaling Pathway.

Activation of PI3Kγ/Akt Pathway Increases Cardiomyocyte HMGB1 Expression in Diabetic Environment

The Effect and Mechanism of -Blocker, Bisoprolol, on the Hypertrophy of Cardiomyocytes of Neonatal Rats Induced by High Glucose Levels

Inhibition of PI-3 Kinase/akt/mtor, but Not Calcineurin Signaling, Reverses Insulin-Like Growth Factor I-induced Protection Against Glucose Toxicity in Cardiomyocyte Contractile Function

Pioglitazone Inhibits Hypertrophy Induced by High Glucose and Insulin in Cultured Neonatal Rat Cardiomyocytes.

Hyperglycemia Induces Cardiomyocyte Hypertrophy In Part Through Pkc Beta 2 Activation In Cultured Neonatal Rat Myocytes

High Levels of Glucose Induce Apoptosis in Cardiomyocyte Via Epigenetic Regulation of the Insulin-Like Growth Factor Receptor

Study on the mechanism of HIF1a-SOX9 in glucose-induced cardiomyocyte hypertrophy

Adipocyte-specific Loss of PPARγ Attenuates Cardiac Hypertrophy.

Abstract 11165: Activation of IGF-1/PI3/GSK-3ss Signaling Prevents High Glucose-induced Transition of Human Cardiac Progenitor Cells into Fibroblasts

High Glucose Induces Cardiac Insulin-Like Growth Factor I Resistance in Ventricular Myocytes: Role of Akt and ERK Activation

High Glucose Activates Prolyl Hydroxylases and Disrupts HIF-α Signaling via the P53/TIGAR Pathway in Cardiomyocyte

Pioglitazone Protected Against Cardiac Hypertrophy Via Inhibiting AKT/GSK3β and MAPK Signaling Pathways.